STOP Fentanyl Overdoses Act of 2023

Bill: 118-hr-3375
Sponsor: Rep. Kuster, Ann M. [D-NH-2]
Introduced: 2023-05-16 in the House
Policy area: Health
Subjects: Civil actions and liability
Congressional oversight
Correctional facilities and imprisonment
Customs enforcement
Drug trafficking and controlled substances
Drug, alcohol, tobacco use
Federal preemption
Government information and archives
Government studies and investigations
Health care costs and insurance
Health care coverage and access
Health information and medical records
Health promotion and preventive care
Intelligence activities, surveillance, classified information
Intergovernmental relations
Law enforcement administration and funding
Medical research
Mental health
Research administration and funding
Retail and wholesale trades
Smuggling and trafficking
State and local government operations

Summary:
action_date: 2023-05-16
text: 

Support, Treatment, and Overdose Prevention of Fentanyl Overdoses Act of 2023 or the STOP Fentanyl Overdoses Act of 2023

This bill addresses data collection, treatment, harm reduction, and other issues related to substance misuse and addiction. It particularly focuses on opioids, fentanyl, and related substances.
 
Specifically, the bill expands surveillance of fentanyl and related substances. This includes requiring a study on how to track overdoses by type of drug (including fentanyl) and awarding grants to states for collecting data about fentanyl-involved overdoses. The bill also provides for (1) training on detecting and handling fentanyl for law enforcement, and (2) grants for forensic laboratories to facilitate surveillance of controlled substances seized by law enforcement.
 
Additionally, the bill establishes and modifies requirements to increase access to treatment and prevention services. For example, the Bureau of Prisons must make certain services, including medication-assisted treatments, available to individuals in its custody. The bill also establishes grants and requires other efforts to expand access to medications that temporarily reverse opioid overdoses (e.g., naloxone) and related harm reduction activities.
 
Furthermore, the bill extends, subject to some conditions, liability protections for those who administer aid in an emergency (commonly known as Good Samaritan laws) to individuals who administer opioid overdose reversal drugs and to individuals who seek medical attention for themselves or on behalf of another for a drug overdose.
 
The bill also requires multiple reports, including a report by the Department of State on foreign sources of certain drugs.


Legislative actions:
action_date: 2023-05-19
text: Referred to the Subcommittee on Health.
action_date: 2023-05-16
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2023-05-16
text: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
action_date: 2023-05-16
text: Introduced in House
action_date: 2023-05-16
text: Introduced in House